COVID-19 infection and BNT162b2 vaccine triggering sarcoid-like lesions in the same patient response to. sarcoid-like reaction in a patient recovering from coronavirus disease 19 pneumonia

Dear Editor, Behbahani et al. recently reported on your journal a rare case of sarcoid granulomas induced by cross- reactivity to COVID-19 infection.1 Since then, different types of COVID-19 vaccines have been produced. Among these, BNT162b2 (Comirnaty®, Pfizer/BioNTech, New York, NY, USA) is an mRNA vaccine encoding the RBD of SARS-CoV-2 spike protein.2 We report a case of cutaneous sarcoid-like granulomatous reaction in a COVID-19 patient, reactivated by the administration of BNT162b2 vaccine.